189 related articles for article (PubMed ID: 30339847)
1. Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever.
Tang K; He S; Zhang X; Guo J; Chen Q; Yan F; Banadyga L; Zhu W; Qiu X; Guo Y
Antiviral Res; 2018 Dec; 160():87-93. PubMed ID: 30339847
[TBL] [Abstract][Full Text] [Related]
2. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
3. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092
[No Abstract] [Full Text] [Related]
4. Antiviral activity of polymethoxylated flavones from "Guangchenpi", the edible and medicinal pericarps of citrus reticulata 'Chachi'.
Xu JJ; Wu X; Li MM; Li GQ; Yang YT; Luo HJ; Huang WH; Chung HY; Ye WC; Wang GC; Li YL
J Agric Food Chem; 2014 Mar; 62(10):2182-9. PubMed ID: 24377463
[TBL] [Abstract][Full Text] [Related]
5. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
[TBL] [Abstract][Full Text] [Related]
6. Identification of a clinical compound losmapimod that blocks Lassa virus entry.
Zhang X; Yan F; Tang K; Chen Q; Guo J; Zhu W; He S; Banadyga L; Qiu X; Guo Y
Antiviral Res; 2019 Jul; 167():68-77. PubMed ID: 30953674
[TBL] [Abstract][Full Text] [Related]
7. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.
Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH
J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767
[TBL] [Abstract][Full Text] [Related]
8. Arenavirus Quasispecies and Their Biological Implications.
Grande-Pérez A; Martin V; Moreno H; de la Torre JC
Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
[TBL] [Abstract][Full Text] [Related]
9. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
Lee AM; Rojek JM; Spiropoulou CF; Gundersen AT; Jin W; Shaginian A; York J; Nunberg JH; Boger DL; Oldstone MB; Kunz S
J Biol Chem; 2008 Jul; 283(27):18734-42. PubMed ID: 18474596
[TBL] [Abstract][Full Text] [Related]
10. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform.
Welch SR; Spengler JR; Genzer SC; Chatterjee P; Flint M; Bergeron É; Montgomery JM; Nichol ST; Albariño CG; Spiropoulou CF
Viruses; 2021 Jun; 13(7):. PubMed ID: 34203149
[TBL] [Abstract][Full Text] [Related]
11. Identification of a broad-spectrum arenavirus entry inhibitor.
Larson RA; Dai D; Hosack VT; Tan Y; Bolken TC; Hruby DE; Amberg SM
J Virol; 2008 Nov; 82(21):10768-75. PubMed ID: 18715909
[TBL] [Abstract][Full Text] [Related]
12. pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors.
York J; Dai D; Amberg SM; Nunberg JH
J Virol; 2008 Nov; 82(21):10932-9. PubMed ID: 18768973
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches in anti-arenaviral drug development.
Lee AM; Pasquato A; Kunz S
Virology; 2011 Mar; 411(2):163-9. PubMed ID: 21183197
[TBL] [Abstract][Full Text] [Related]
14. The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein.
Zhang X; Tang K; Guo Y
Antiviral Res; 2020 Feb; 174():104701. PubMed ID: 31877348
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
Ortiz-Riaño E; Ngo N; Devito S; Eggink D; Munger J; Shaw ML; de la Torre JC; Martínez-Sobrido L
J Virol; 2014 Jan; 88(2):878-89. PubMed ID: 24198417
[TBL] [Abstract][Full Text] [Related]
16. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Antiviral Compounds Targeting Entry of Hantaviruses.
Mayor J; Torriani G; Engler O; Rothenberger S
Viruses; 2021 Apr; 13(4):. PubMed ID: 33923413
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism.
Spence JS; Melnik LI; Badani H; Wimley WC; Garry RF
J Virol; 2014 Aug; 88(15):8556-64. PubMed ID: 24850726
[TBL] [Abstract][Full Text] [Related]
19. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
Takenaga T; Zhang Z; Muramoto Y; Fehling SK; Hirabayashi A; Takamatsu Y; Kajikawa J; Miyamoto S; Nakano M; Urata S; Groseth A; Strecker T; Noda T
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578344
[TBL] [Abstract][Full Text] [Related]
20. The curious case of arenavirus entry, and its inhibition.
Nunberg JH; York J
Viruses; 2012 Jan; 4(1):83-101. PubMed ID: 22355453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
